Nexus News

Browse Mpox

June 19, 2023

Research Letter Outlines Issues in Distribution of Mpox Vaccine in the United States

Mpox

May 24, 2023

Interim Clinical Treatment Considerations for Severe Mpox Infections

Mpox

May 24, 2023

Deep-Learning Algorithm Available in PoxApp May Help Detect Mpox Lesions

Mpox

May 24, 2023

Special Communication Provides Overview of Mpox Data From 1970s to Present

Mpox

May 24, 2023

Mpox Cases Among Cisgender Women and Pregnant Individuals

Mpox

May 25, 2023

How Stable Is the Mpox Virus on Surfaces?

Mpox

June 08, 2023

Study Examines Efficacy of JYNNEOS Vaccine in Preventing Mpox

Mpox

August 02, 2023

Mpox Virus Neutralization May Be Complement-Dependent, Study Finds

Mpox

August 09, 2023

Mpox Messages Mentioning At-Risk Populations Could Contribute to Stigmatization

Mpox

August 21, 2023

Researchers Spotlight TRIM5α as Possible Treatment Option for Patients With Mpox

Mpox

September 20, 2023

Vaccines May Lessen Duration, Severity of Mpox Reinfections

Mpox

January 31, 2024

New Strategies Needed to Improve Health-Seeking Behaviors Among Sexual Minority Men With or at Risk of Mpox

Mpox

Issues in Dermatology

May 24, 2023

Virtual Wards May Be Effective for Patients With Mpox, Highlight Potential New Treatment Route for Patients in Future Outbreaks

Mpox

May 25, 2023

Tecovirimat May Be Safer and More Effective at Treating Patients With Mpox Than Other Antivirals

Mpox

May 25, 2023

FDA Grants Emergency Use Authorization to DiaCarta’s Mpox Virus Test QuantiVirus MPXV

Mpox

May 25, 2023

Small Resurgence of Mpox Cases Identified in Chicago Area

Mpox

June 01, 2023

CDC Highlights the Need for Continued Urban Surveillance of Mpox Ahead of Anticipated Summer Resurgence in Cases

Mpox

July 13, 2023

UCLA Receives $925,000 Grant to Investigate Mpox Outbreaks in the United States

Mpox

December 13, 2023

Mpox Outbreak in Democratic Republic of the Congo: Updates

Mpox

February 28, 2024

Mpox Test Uses CRISPR Technology to Simplify Testing

Mpox

March 13, 2024

COH04S1 Vaccine May Provide Protection Against Mpox and COVID-19 Infections

Mpox

May 25, 2023

CDC Advises At-Risk Individuals to Get Vaccinated Ahead of Potential Mpox Outbreak

Mpox

May 25, 2023

New Report From Human Rights Campaign Details Shortcomings in Mpox Vaccination for Black Patients

Mpox

May 25, 2023

Patients With Advanced HIV and Mpox Infection May Be at Greater Risk of Severe Infection and Death

Mpox

May 25, 2023

African Countries Continue to Struggle With Mpox Infections and Limited Resources to Slow Its Spread

Mpox

May 25, 2023

Sharp Decline in Mpox Virus Cases Likely Attributed to Multiple Factors

Mpox

May 25, 2023

Last Week of April Sees Zero New Mpox Cases, CDC Reports

Mpox

May 25, 2023

Global Health Emergency for Mpox Outbreak Comes to an End

Mpox

May 25, 2023

CDC Sounds the Alarm for Potential New Mpox Outbreak During the Summer Months

Mpox

July 07, 2023

Vaccines Offered at International Mr. Leather Event May Have Aided in Deterring Mpox Outbreak

Mpox

November 08, 2023

Experts Urge Eligible Individuals to Receive JYNNEOS Vaccines to Protect Against Mpox

Mpox

January 10, 2024

Addressing Stigma Against Gay and Bisexual Men in the Context of the Mpox Outbreak in the Democratic Republic of the Congo

Mpox

Issues in Dermatology

April 10, 2024

Experts Urge At-Risk Patients to Vaccinate for Mpox as U.S. Cases Rise

Mpox

April 17, 2024

Mpox Vaccine Protection Found to Be Shorter Than Previously Thought

Mpox

Browse Mpox

Research Letter Outlines Issues in Distribution of Mpox Vaccine in the United States

Interim Clinical Treatment Considerations for Severe Mpox Infections

Deep-Learning Algorithm Available in PoxApp May Help Detect Mpox Lesions

Special Communication Provides Overview of Mpox Data From 1970s to Present

Mpox Cases Among Cisgender Women and Pregnant Individuals

How Stable Is the Mpox Virus on Surfaces?

Study Examines Efficacy of JYNNEOS Vaccine in Preventing Mpox

Mpox Virus Neutralization May Be Complement-Dependent, Study Finds

Mpox Messages Mentioning At-Risk Populations Could Contribute to Stigmatization

Researchers Spotlight TRIM5α as Possible Treatment Option for Patients With Mpox

Vaccines May Lessen Duration, Severity of Mpox Reinfections

New Strategies Needed to Improve Health-Seeking Behaviors Among Sexual Minority Men With or at Risk of Mpox

Virtual Wards May Be Effective for Patients With Mpox, Highlight Potential New Treatment Route for Patients in Future Outbreaks

Tecovirimat May Be Safer and More Effective at Treating Patients With Mpox Than Other Antivirals

FDA Grants Emergency Use Authorization to DiaCarta’s Mpox Virus Test QuantiVirus MPXV

Small Resurgence of Mpox Cases Identified in Chicago Area

CDC Highlights the Need for Continued Urban Surveillance of Mpox Ahead of Anticipated Summer Resurgence in Cases

UCLA Receives $925,000 Grant to Investigate Mpox Outbreaks in the United States

Mpox Outbreak in Democratic Republic of the Congo: Updates

Mpox Test Uses CRISPR Technology to Simplify Testing

COH04S1 Vaccine May Provide Protection Against Mpox and COVID-19 Infections

CDC Advises At-Risk Individuals to Get Vaccinated Ahead of Potential Mpox Outbreak

New Report From Human Rights Campaign Details Shortcomings in Mpox Vaccination for Black Patients

Patients With Advanced HIV and Mpox Infection May Be at Greater Risk of Severe Infection and Death

African Countries Continue to Struggle With Mpox Infections and Limited Resources to Slow Its Spread

Sharp Decline in Mpox Virus Cases Likely Attributed to Multiple Factors

Last Week of April Sees Zero New Mpox Cases, CDC Reports

Global Health Emergency for Mpox Outbreak Comes to an End

CDC Sounds the Alarm for Potential New Mpox Outbreak During the Summer Months

Vaccines Offered at International Mr. Leather Event May Have Aided in Deterring Mpox Outbreak

Experts Urge Eligible Individuals to Receive JYNNEOS Vaccines to Protect Against Mpox

Addressing Stigma Against Gay and Bisexual Men in the Context of the Mpox Outbreak in the Democratic Republic of the Congo

Experts Urge At-Risk Patients to Vaccinate for Mpox as U.S. Cases Rise

Mpox Vaccine Protection Found to Be Shorter Than Previously Thought

Editor's Picks

New Resolution to Scrap AAD DEI Programs Ignites Argument Over Diversity in Dermatology

Cutaneous Chronic Graft-vs-Host Disease: Role of Patient-Reported Outcomes in Measuring Severity and Survival

Lifileucel Receives FDA Accelerated Approval for Unresectable or Metastatic Melanoma